Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Conditions
Triple Negative Breast Cancer · Non Small Cell Lung Cancer · Metastatic Breast Cancer · Metastatic Non-Small Cell Lung Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Natera, Inc. (Data and Specimen Analysis Only), San Carlos, California, United States
Hartford Healthcare, Hartford, Connecticut, United States
WCHN Norwalk Hospital - Data Collection, Norwalk, Connecticut, United States
Baptist Alliance - McI, Miami, Florida, United States
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center @ Commack, Commack, New York, United States
Memorial Sloan Kettering Westchester, Harrison, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
Lehigh Valley Health Network, Allentown, Pennsylvania, United States
Study leads
Amy Xu, MD, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center